Use of postmenopausal hormone therapies and risk of histology- and hormone receptor-defined breast cancer: results from a 15-year prospective analysis of NIH-AARP cohort

BACKGROUND: Menopausal hormone therapy (MHT) increases breast cancer (BC) risk, but cohort studies largely consider use only at enrollment. Evidence is limited on how changes in MHT use alter the magnitude of risk, and whether risk varies between invasive and in situ cancer, by histology or by hormo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shao-Ming, Pfeiffer, Ruth M., Gierach, Gretchen L., Falk, Roni T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687781/
https://www.ncbi.nlm.nih.gov/pubmed/33239054
http://dx.doi.org/10.1186/s13058-020-01365-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687781/
https://www.ncbi.nlm.nih.gov/pubmed/33239054
http://dx.doi.org/10.1186/s13058-020-01365-9

Ejemplares similares